Net profit of SMS Pharmaceuticals rose 20.20% to Rs 14.10 crore in the quarter ended September 2024 as against Rs 11.73 crore during the previous quarter ended September 2023. Sales rose 18.07% to Rs 196.75 crore in the quarter ended September 2024 as against Rs 166.64 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales196.75166.64 18 OPM %15.9916.69 - PBDT28.1623.06 22 PBT19.5415.16 29 NP14.1011.73 20 Powered by Capital Market - Live News

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live News

SMS Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

The Board of SMS Pharmaceuticals at its meeting held on 05 August 2024 has approved to incorporate a Subsidiary Company in India as a Company for Contract Research Organization (CRO) services on Peptides. Powered by Capital Market - Live News

Net profit of SMS Pharmaceuticals rose 76.45% to Rs 16.48 crore in the quarter ended June 2024 as against Rs 9.34 crore during the previous quarter ended June 2023. Sales rose 21.51% to Rs 164.45 crore in the quarter ended June 2024 as against Rs 135.34 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales164.45135.34 22 OPM %20.3819.35 - PBDT30.2120.37 48 PBT21.8312.68 72 NP16.489.34 76 Powered by Capital Market - Live News